cmpd semaglutide FDA issues warning about some compounded versions of for diabetes, weight loss Sema Initial Program – 6

While formal pharmacokinetic studies of GLP-1RA co-administration with these IBD drugs have not been conducted, clinicians should monitor for unexplained changes in therapeutic response, particularly during GLP-1RA initiation and dose escalation, and consider staggering oral medications when feasible

These findings provide insight into the potential benefits of GLP-1 RAs, but they are preliminary and warrant further investigation

Molecular mechanisms of the therapeutic effect of selenium nanoparticles in hepatocellular carcinoma

Long M, Cai L, Li W, et al

When used alongside Semaglutide, it can help curb cravings and support sustained weight loss